Evaluation of autologous cell transplantation without melanocyte-keratinocyte culture in suspension and gel form in the treatment of patients with persistent vitiligo
Phase 1
- Conditions
- Vitiligo.disorders of pigmentation
- Registration Number
- IRCT20200127046282N22
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Having no treatment within past 6 months
No pregnancy or breast-feeding
Have a diagnosis of vitiligo with depigmented patch more than 5 cm despite receiving at least 3 months active treatment
No infection at recipient site
No history of keloid and or koebner phenomenon
No history of active hepatitis the B, C, or AIDS
No active uncontrolled chronic systemic disease
Exclusion Criteria
Vitiligo patients with active or progressive disease within last 12 months.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Repigmentation rate. Timepoint: Before, 1, 3 and 6 months after treatment. Method of measurement: The amount of melanin in the treated areas compared to before treatment using a maxameter device.
- Secondary Outcome Measures
Name Time Method